Cardiac regeneration is a promising and evolving field of research focused on restoring damaged or injured heart tissue. Unlike many other tissues in the body, the heart has limited regenerative capacity, and injuries such as myocardial infarction (heart attack) can lead to irreversible damage. The goal of cardiac regeneration is to stimulate the growth of new, functional heart tissue to replace or repair damaged areas. Various approaches are being explored, including the use of stem cells, tissue engineering, and regenerative medicine techniques. Stem cells, with their potential to differentiate into various cell types, have shown promise in promoting the regeneration of cardiac cells. Additionally, researchers are investigating ways to stimulate the heart's endogenous regenerative mechanisms, encouraging the growth of new blood vessels and cardiomyocytes. While still in the early stages of development, the field of cardiac regeneration holds the potential to revolutionize the treatment of heart diseases and improve outcomes for individuals with damaged cardiac tissue.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States